时代中国控股(01233.HK)拟分拆时代邻里控股并于港交所主板上市
格隆汇9月9日丨时代中国控股(01233.HK)公告,公司建议将公司附属公司时代邻里股份分拆,并透过分派及将时代邻里新股份进行全球发售(包括优先发售)的方式于联交所主板独立上市。时代邻里股份于联交所主板独立上市构成公司根据第15项应用指引分拆时代邻里。联交所已确认公司可进行建议分拆。
于2019年9月9日,时代邻里向联交所递交上市申请表格(A1表格),以申请将时代邻里股份于联交所主板上市及批准买卖。完成建议分拆及上市后,公司将不会保留时代邻里已发行股的任何权益,而时代邻里将不再为公司的附属公司。
分拆集团主要从事提供物业管理服务、非业主增值服务、社区增值服务及其他专业服务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.